The aim of the study was a head‐to‐head comparison of GDF‐15 and sST2 for prediction of arrhythmic death (AD) and all‐cause mortality in patients with non‐ischaemic DCM. The gene discussed is GDF15; the disease is familial dilated cardiomyopathy.